Vaccine

  • PDF
  • Print

Swine Flu Vaccine Linked to Paralysis

  • Wednesday, 04 November 2009 06:56
  • Written by fuyicn

It is not any alleged “Swine Flu” or H1N1 “virus” that is the danger to the lives of our loved ones, our children, our pregnant mothers. We are being literally panicked by WHO, CDC, the US Government and uncritical mass media into demanding what amounts to legalized toxins as a “guard” against a disease so far milder than a common cold.

 

The few details that have managed to leak out regarding the contents of the fluids that major pharmaceutical companies want to inject into our veins confirm what I have been writing since the first alleged outbreak of Swine Flu in the environs of a factory pig farm in Veracruz Mexico.

 

The declaration by WHO of  Phase 6 “Pandemic Level” global health emergency was a political decision which had no relation to any proven “virus threat.” It had to do at the least with a multibillion dollar injection of hyper-profits into the coffers of a tiny handful of global vaccine giants—GlaxoSmithKline, Roche (Gilead Science Inc), Baxter Labs, Novartis,  Sanofi Pasteur and a few elite other drug giants.

 

More, the current H1N1 fear campaign from WHO, the German Robert Koch Institute, the US Government’s CDC, appears on serious examination to have to do not with safeguarding the public health, but rather with a long-term agenda of political control of populations through deliberate means of making them ill, weak, partly paralyzed or otherwise too weak to focus on the increasingly obvious social crisis facing us all, the global breakdown of the dollar system. Why else would allegedly responsible governments from the United States to the Federal Republic of Germany, from Britain to France, embrace such a manifest health hoax?

 

The simplest research of a high school pupil using official WHO and other government sources, can demonstrate this. If you doubt this, just commission your school age children to demonstrate, using only official sources, published on the internet, that there is no sound, public health reason to declare any special measures, let alone to authorize “fast track” rollout of new vaccines, untested, for mass injection in the population. Tell them that the students who make the best case from only official sources, will get the top honors in the course.   

 

UK report of neurological damage from vaccine

According to a confidential warning letter written on July 29, 2009, a copy of which was leaked to the British newspaper, Daily Mail, the UK Government’s Health Protection Agency head of Immunization Department, Prof. Elizabeth Miller, warned British neurologists that the swine flu vaccine, which was briefly used in a mass vaccination program in 1976 in the USA until it was abruptly withdrawn because of dangerous side effects, is linked to Guillain-Barre Syndrome (GBS), a potentially deadly and nerve crippling of the central nervous system. Guillain-Barre Syndrome attacks the lining of the nerves, causing paralysis and inability to breathe, and can be fatal. It can cause paralysis of the breathing muscles that can cause death by suffocation.

The warning letter of Prof. Miller states, “The vaccines used to combat an expected swine influenza pandemic in 1976 were shown to be associated with GBS and were withdrawn from use." The US Government was forced in the 1976 Swine Flu scandal to pay out millions of dollars in damages to victims of GBS who had received the vaccine.

The UK Government plans to inject 13 million British citizens beginning October with virtually untested H1N1 vaccines. The British Neurological Surveillance Unit (BNSU), part of the British Association of Neurologists, has been asked to monitor closely any cases of GBS as the vaccine is rolled out. One senior neurologist told the press off-record, “I would not have the swine flu jab because of the GBS risk.”

Miller’s letter was reportedly sent to 600 British neurologists on July 29, a sign that there is concern at the highest levels that the vaccine itself could cause serious complications. The letter notes, referring to the similar swine flu vaccination process in the USA in 1976 that “more people died from the vaccination than from swine flu; some 500 cases of GBS were found; vaccines may have increased risk of GBS by 800%; the US vaccine was withdrawn after just ten weeks when Government scientists confirmed the link with GBS; the US Government then was forced to pay tens of millions of dollars to those affected. They monitored that within days, symptoms of GBS were reported among those who had been immunised and 25 people died from respiratory failure after severe paralysis. One in 80,000 people came down with the condition. In contrast, just one person died of swine flu.

Notably, the Obama Administration has issued a special ruling exempting the vaccine makers from all liability from the vaccines. Most alarming in this context is the fact that the new vaccine has not been sufficiently tested and that the effects, especially on children, are unknown. Yet small children and pregnant mothers are the first priority to be vaccinated under WHO recommendations.


However, as leading European epidemiologists confirm privately, the effects of the so-called H1N1 Influenza A or “Swine Flu” are to date extremely mild, comparable to a common cold and disappear in a few days with bed rest. The deaths, as CDC and other health agencies have had to admit, all took place in patients with previous severe respiratory problems or other severe illness, and have in no known case been definitively linked to Swine Flu. The deaths were what epidemiologists term “opportunistic” that is “coincidental” not causal.


GBS however, which is believed linked to adjuvants present in the new vaccines, can cause paralysis and death. One woman, Hilary Wilkinson, was stricken with GBS and had to be fed through a drip while needing a tracheotomy just to breathe. It took her three months in the hospital to learn how to walk and talk again. On the topic of the swine flu vaccine, she says today, "It makes me feel wary that the Government is rolling out this vaccine without any clear idea of the GBS risk, if any. I wouldn't wish it on anyone."

 

An 800% rise in GBS risk

Another letter with a warning about the swine flu vaccine from the Association of British Neurologists, signed by Dr. Rustam Al-Shahi Salman and Professor Patrick Chinnery, says, "Following the 1976 program of vaccination against swine influenza in the US, a retrospective study found a possible eight-fold increase in the incidence of GBS." That is 800% increase after vaccination of 40 million Americans was done on a similar “health emergency” basis before abruptly being withdrawn. The 1976 swine flu mass vaccination campaign was abandoned after hundreds of cases of GBS were diagnosed and 25 died.

An emergency mass vaccination program was backed by President Gerald Ford that year because Center for Disease Control head, Dr. David Sencer, convinced the White House that the swine flu strain was similar to the one responsible for the 1918-19 pandemic, which he claimed had killed half a million Americans and 20 million people worldwide. Sencer was forced to resign in disgrace months later. The current CDC and WHO hysteria campaign over “H1N1 Influenza A Swine Flu” bears ominous similarities to that of 1976. 

According to the British Dr Tom Jefferson, co-ordinator of the vaccines section of the influential Cochrane Collaboration, an independent British group that reviews drug research, says, “New vaccines never behave in the way you expect them to. It may be that there is a link to GBS, which is certainly not something I would wish on anybody. But it could end up being anything because one of the additives in one of the vaccines is a substance called squalene, and none of the studies we’ve extracted have any research on it at all.” Squalene, a naturally occurring enzyme, could potentially cause so-far-undiscovered side effects.

 

In other words, what we have with the new versions of H1N1 “swine flu” vaccine is an untested, potentially dangerous cocktail of chemicals and viral fragments that could plausibly be linked to a devastating neurological condition, or worse.

 

The doctors and scientists are warning about the possibility of dangerous neurological side effects precisely because the government is failing to do so. Governments and pharmaceutical companies don't want people to know about risks associated with the vaccine, so they don't talk about them. Nor do they reveal the rather startling fact that the vaccine has never been tested on children or expectant mothers even though those are the two primary groups being targeted for the vaccine.

 

Vaccines are the bedrock of the pharmaceutical industry's profit centers. Through vaccines, the drug companies can ensure generations of future profits from diseases that have been identified in numerous studies as triggered or worsened by vaccines, including Alzheimer's, cancer, autism, Parkinson's disease, and others.

British Conservative Party Health Parliament Spokesman, Mike Penning has stated, “The last thing we want is secret letters handed around experts within the NHS. Our job is to make sure that the public knows what’s going on. Why is the Government not being open about this? It’s also very worrying if doctors, who will be administering the vaccine, aren’t being warned.”


F. William Engdahl is a frequent contributor to Global Research.  Global Research Articles by F. William Engdahl
  • PDF
  • Print

H1N1 Vaccine: Examining Benefits Vs. Risk For Individuals

  • Sunday, 01 November 2009 17:56
  • Written by fuyicn
The CDC has released 3.4 million doses of the H1N1,or swine flu,vaccine, which will be distributed throughout the 50 states. More than 251 million doses of the vaccine will be administered to patients throughout flu season. 
Although the panic factor surrounding the potential threat of a swine flu pandemic is
high, lethal cases of H1N1 have been relatively low. Out of the almost 30,000 cases of swine flu that have been reported, most cases are mild. As of early September 127 people in the U.S. had died of swine flu.   Pat El-Hinnawy, H1N1 Public Affairs Specialist for the FDA, says "So far, [the H1N1 virus] has not shown a very high virulence or a very high mutation rate. For most of the people who get it, it's not a very severe set of symptoms." 
That's causing some experts to question the necessity of getting vaccinated. Dr. Arthur Douville, a neurologist from Los Gatos, California, asked, "How widely should we vaccinate against an influenza virus that is relatively modest in its effects, and which the exact extent of the pandemic we can't really predict?" Good question. When it comes to public health, there's a fine line between harm and safety. 
Swine flu is not a new virus. In 1976 there was a spread of infections of the same virus and the government set a large vaccination program in motion. Millions of Americans were vaccinated, but many suffered adverse events such as Guillain-Barre Syndrome.  GBS is a neurological disorder where nerve damage can result in paralysis and loss of muscle function, potentially causing death. The vaccination program was abandoned after three months. 
Vaccination technology has come a long way since the late 70's, as Dr. Jonathon Fielding, a public health officer for the County of Los Angeles, points out. "We have been making vaccines for 33 years since then. I think the rate of complications of vaccine administration is very very small, and the benefits are so great compared to the very small risk." 
Today's H1N1 vaccine is identical to the seasonal influenza vaccine distributed every year, except that instead of injecting the flu virus, H1N1 is injected. Both the FDA and CDC say the risks are similar to those associated with getting a vaccine for the common flu.  Arleen Porcell-Pharr, a Public Affairs Specialist for the CDC, says "We expect the 2009 H1N1 influenza vaccine to have a similar safety profile as seasonal flu vaccines, which have very good safety track records."  
Samantha Ellinwood, a 1st year medical student at UC Davis believes strongly in her decision to get vaccinated, not only because her school requires it, but because she sees it as part of her obligation as a member of the health-care profession. "Honestly, the risks involved are a lot
lower in getting the vaccine than not getting it," she said. "I am in a position where I could get a lot of people sick, especially people who are immune compromised. It's important for people like me to get vaccinated."
However not everyone is so confident in the safety of the new vaccine for every member of society. Dr. Douville said that he is telling some patients not to get vaccinated.  "If you already have demonstrated that you have some risk of getting a Guillain-Barre like illness, then maybe we shouldn't take that risk. It depends on the risk of the disease. So far, H1N1 is relatively modest risk."
Some critics say the new vaccine has not been thoroughly tested. There is currently a study on the H1N1 vaccine going on in Denver, CO that has yet to publish results.  Jeffry John Aufderheide, who works for VacTruth, a watchdog group, says it's too early to be widely distributing the vaccine. "The trials didn't even start until last week and they are already calling it safe. How are they able to say something is safe without testing it?" 
The CDC is confident in the safety of the H1N1 vaccine because it is very similar to the vaccine for the common flu, which has proven not to be dangerous to the majority of the population. The CDC currently recommends that pregnant women, caregivers, healthcare and medical personnel, be among the first to receive the 2009 H1N1 vaccine. Additionally recommended for vaccination
are all people between the ages of 6 months and 24 years as well as people ages 25 to 65 with health conditions associated with medical complications from influenza. The inoculation also comes in the form of a nasal spray, which can be risky for pregnant women and people with chronic medical conditions. 
  • PDF
  • Print

H1N1 Vaccine: Examining Benefits Vs. Risk For Individuals

  • Sunday, 01 November 2009 17:56
  • Last Updated ( Sunday, 01 November 2009 17:58 )
  • Written by fuyicn
The CDC has released 3.4 million doses of the H1N1,or swine flu,vaccine, which will be distributed throughout the 50 states. More than 251 million doses of the vaccine will be administered to patients throughout flu season. 
Although the panic factor surrounding the potential threat of a swine flu pandemic is
high, lethal cases of H1N1 have been relatively low. Out of the almost 30,000 cases of swine flu that have been reported, most cases are mild. As of early September 127 people in the U.S. had died of swine flu.   Pat El-Hinnawy, H1N1 Public Affairs Specialist for the FDA, says "So far, [the H1N1 virus] has not shown a very high virulence or a very high mutation rate. For most of the people who get it, it's not a very severe set of symptoms." 
That's causing some experts to question the necessity of getting vaccinated. Dr. Arthur Douville, a neurologist from Los Gatos, California, asked, "How widely should we vaccinate against an influenza virus that is relatively modest in its effects, and which the exact extent of the pandemic we can't really predict?" Good question. When it comes to public health, there's a fine line between harm and safety. 
Swine flu is not a new virus. In 1976 there was a spread of infections of the same virus and the government set a large vaccination program in motion. Millions of Americans were vaccinated, but many suffered adverse events such as Guillain-Barre Syndrome.  GBS is a neurological disorder where nerve damage can result in paralysis and loss of muscle function, potentially causing death. The vaccination program was abandoned after three months. 
Vaccination technology has come a long way since the late 70's, as Dr. Jonathon Fielding, a public health officer for the County of Los Angeles, points out. "We have been making vaccines for 33 years since then. I think the rate of complications of vaccine administration is very very small, and the benefits are so great compared to the very small risk." 
Today's H1N1 vaccine is identical to the seasonal influenza vaccine distributed every year, except that instead of injecting the flu virus, H1N1 is injected. Both the FDA and CDC say the risks are similar to those associated with getting a vaccine for the common flu.  Arleen Porcell-Pharr, a Public Affairs Specialist for the CDC, says "We expect the 2009 H1N1 influenza vaccine to have a similar safety profile as seasonal flu vaccines, which have very good safety track records."  
Samantha Ellinwood, a 1st year medical student at UC Davis believes strongly in her decision to get vaccinated, not only because her school requires it, but because she sees it as part of her obligation as a member of the health-care profession. "Honestly, the risks involved are a lot
lower in getting the vaccine than not getting it," she said. "I am in a position where I could get a lot of people sick, especially people who are immune compromised. It's important for people like me to get vaccinated."
However not everyone is so confident in the safety of the new vaccine for every member of society. Dr. Douville said that he is telling some patients not to get vaccinated.  "If you already have demonstrated that you have some risk of getting a Guillain-Barre like illness, then maybe we shouldn't take that risk. It depends on the risk of the disease. So far, H1N1 is relatively modest risk."
Some critics say the new vaccine has not been thoroughly tested. There is currently a study on the H1N1 vaccine going on in Denver, CO that has yet to publish results.  Jeffry John Aufderheide, who works for VacTruth, a watchdog group, says it's too early to be widely distributing the vaccine. "The trials didn't even start until last week and they are already calling it safe. How are they able to say something is safe without testing it?" 
The CDC is confident in the safety of the H1N1 vaccine because it is very similar to the vaccine for the common flu, which has proven not to be dangerous to the majority of the population. The CDC currently recommends that pregnant women, caregivers, healthcare and medical personnel, be among the first to receive the 2009 H1N1 vaccine. Additionally recommended for vaccination
are all people between the ages of 6 months and 24 years as well as people ages 25 to 65 with health conditions associated with medical complications from influenza. The inoculation also comes in the form of a nasal spray, which can be risky for pregnant women and people with chronic medical conditions. 
  • PDF
  • Print

WHO Emphasizes H1N1 Vaccine Safety

  • Sunday, 01 November 2009 17:14
  • Written by fuyicn

The WHO on Tuesday continued to express confidence in the H1N1 (swine flu) vaccine as few mild adverse effects have been reported by patients participating in China's vaccine campaign, the Associated Press reports. Out of the 39,000 people in China who received the H1N1 vaccine, four reported experiencing side effects such as muscle cramps and headache, according to WHO spokesman Gregory Hartl.

"Adverse events are fully to be expected, especially these mild types," Hartl told journalists Tuesday, Agence France-Presse reports. "The vaccine is the single most important tool that we have against influenza," he said, adding he believes it vital for health care workers.

Hartl emphasized the safety of the H1N1 vaccines, "which have already been approved, have been used for years and years and years in their seasonal vaccine formulation and have been shown to be among the safest vaccines that exist," Reuters reports.

In a second story, Reuters examines several scenarios of how the H1N1 pandemic will play out as the second wave of the virus moves through the Northern hemisphere.

"Whatever the virus does, the world lacks the capacity to vaccinate most of the population against flu," leaving poor nations dependent upon the H1N1 vaccine donations over wealthy countries, Reuters writes. Though "the first wave of the swine flu pandemic affected wealthier nations like the United States, Australia and Japan, where it is still active," the U.N's senior technical expert on influenza, Julie Hall, said there is now evidence "that the virus is beginning to penetrate into some of the poorest communities in the world".

In related news, SabaNews.net reports Abdul Kareem Rasa, Morocco's minister of public health and population, on Tuesday appealed to the WHO for one million doses of the H1N1 vaccine for Muslim pilgrims from poor countries .

Saudi Arabian health officials say they are prepared to "welcome some three million pilgrims during the annual hajj to Mecca in December amid the heightened alert on the swine flu pandemic," the AFP reports. In addition to calling upon hajj participants to receive the seasonal flu shot and, if available, the H1N1 vaccine, a Saudi health official said the country has four million doses of vaccine and hospitals prepared to deal with H1N1. The AFP notes, "Saudi Arabia has to date reported 9,000 cases of swine flu and 35 deaths from the disease, one of the highest levels of contamination in the Arab world" (10/5).

Meanwhile, Chinese health officials reported that an 18-year-old women in Lhasa, the capital of the far western Tibet Autonomous Region, had become the country's first death from H1N1, the Wall Street Journal reports . In response, the Chinese government "'urgently' sent 200,000 doses of influenza A (H1N1) vaccine to the region … in a bid to contain the virus, China's health ministry said in a statement on its website," AFP/Times of India reports.

© Henry J. Kaiser Family Foundation. All rights reserved.